12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Second Sight Medical EYES stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59.5 million.
  • Enveric Biosciences ENVB shares increased by 7.4% to $0.67. The company's market cap stands at $21.9 million.
  • Alterity Therapeutics ATHE stock rose 7.11% to $1.05. The company's market cap stands at $42.1 million.
  • Also check out this: Executives Buy Over $6M Of 5 Penny Stocks
  • 180 Life Sciences ATNF shares moved upwards by 6.98% to $3.37. The company's market cap stands at $114.6 million.
  • Sonnet BioTherapeutics SONN shares increased by 6.87% to $0.34. The company's market cap stands at $20.4 million.
  • Achieve Life Sciences ACHV shares moved upwards by 6.39% to $8.15. The market value of their outstanding shares is at $77.0 million.

Losers

  • Nuvectis Pharma NVCT shares fell 13.2% to $6.9 during Tuesday's pre-market session. The company's market cap stands at $81.5 million.
  • Editas Medicine EDIT stock fell 12.01% to $17.0. The company's market cap stands at $1.1 billion.
  • Reviva Pharmaceuticals RVPH stock decreased by 10.92% to $1.55. The market value of their outstanding shares is at $23.4 million.
  • Karyopharm Therapeutics KPTI stock fell 9.77% to $9.24. The company's market cap stands at $698.0 million. As per the press release, Q4 earnings came out today.
  • Novavax NVAX shares fell 9.29% to $86.0. The company's market cap stands at $6.5 billion.
  • Forte Biosciences FBRX shares decreased by 8.98% to $1.42. The market value of their outstanding shares is at $20.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...